ANGPTL8/betatrophin was enriched in liver hepatocellular carcinoma (LIHC) as well as normal controls (Supplementary Figure S5), and was significantly lower in breast invasive carcinoma (BRCA) and cholangiocarcinoma (CHOL) than in normal samples (Figure 1). Here, ANGPTL8 is linked to cholangiocarcinoma.